The European Medicines Agency (EMA) is located in Amsterdam, the Netherlands. Serving a population of 500 million citizens, we promote and protect public and animal health in EU Member States, as well as the countries of the European Economic Area, by ensuring that all medicines available on the EU market are safe, effective and of high quality.
Within the Agency's veterinary activities, the European Surveillance of Veterinary Antimicrobial Consumption (ESUAvet) is one of EMA's high-profile outputs supporting the fight against antimicrobial resistance (AMR). It covers the collection and analysis of data on antimicrobial sales and use in animals reported by Member States under Article 57 of Regulation (EU) 2019/6.
The ESUAvet team works closely with Member States, the European Commission and the Committee for Veterinary Medicinal Products (CVMP) to deliver scientific and regulatory surveillance outputs, such as ESUAvet reports and dashboards, that have uptake and impact across Europe and internationally. The team also contributes to cross-agency projects such as the joint inter-agency antimicrobial consumption and resistance analysis (JIACRA) reports.
The team is a close-knit group of five colleagues working collaboratively to deliver high-quality surveillance activities and scientific support. It works as part of the European Medicines Regulatory Network.